Acura Pharma Balance Sheet - Quarterly (OTCMKTS:ACUR)

Add to My Stocks
$0.13 $0.03 (18.75%) ACUR stock closing price Sep 21, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Acura Pharma stock analysis. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Acura Pharma stock analysis. Quarterly results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $5.43M and shareholders equity of $-2.62M. Acura Pharma revenue and Acura Pharma operating cash flow are important in understanding the financial capacity of the company.

View and download Acura Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities--------3.51M7.68M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment--2.51M---2.8M---
Accumulated Depreciation--1.83M---1.94M---
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable----------
Current Portion Long-Term Debt1.5M2.22M2.69M2.91M2.85M2.79M2.37M2.68M2.62M2.57M
Current Portion Capital Leases----------
Accrued Expenses1.56M1.56M1.63M--1.07M---1.2M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt1.42M---1.43M2.14M2.97M3.5M4.16M4.8M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus380.29M380.23M380.14M380.03M376M375.88M375.76M375.62M375.47M375.32M
Retained Earnings-383.13M-381.87M-380.38M-378.64M-376.44M-374.29M-374.69M-376.23M-373.98M-370.69M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity-2.62M-1.42M-0.02M1.6M-0.32M1.71M1.18M-0.48M1.63M4.75M
Total Liabilities & Shareholders Equity2.81M3.04M4.6M7.26M6.24M8.85M8.2M7.73M10.22M14.42M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Acura Pharma stock price by looking at Acura Pharma historical stock prices. One can compare PE with industry average by looking at the Acura Pharma PE ratio chart. The common balance sheet items are:

  • Assets: ACUR total assets, which was at $2.81M for 2018 Q2 is a balance sheet item representing value of what Acura Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Acura Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for ACUR stock stand at $5.43M.

Acura Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover